HONG KONG – For the first time in 16 years, China is planning to implement an updated version of its drug administration law. The CFDA also is set to revise the country's provisions for drug registration in efforts to upgrade its health care industry. Major proposed changes to the drug administration law – which covers both pharmaceuticals and medical devices – are intended to reduce regulations in line with other major markets.